XClose

Phylogenetics And Networks for Generalised HIV Epidemics in Africa

Menu

London School of Hygiene and Tropical Medicine

The London School of Hygiene & Tropical Medicine is a world-leading centre for research and postgraduate education in public and global health.

Part of the University of London, the LSHTM is the largest institution of its kind in Europe with a remarkable depth and breadth of expertise encompassing many disciplines. LSHTM staff collaborate with researchers in over 100 countries around the world, utilizing the school’s critical mass of multidisciplinary expertise which includes clinicians, epidemiologists, statisticians, social scientists, economists, molecular biologists, immunologists, ophthalmologists, anthropologists, virologists, pharmacologists and nutritionists.

LSHTM’s mission is to improve health and health equity in the UK and worldwide; working in partnership to achieve excellence in public and global health research, education and translation of knowledge into policy and practice.

The School was named the world’s leading research-focused graduate school in the Times Higher Education World Rankings (October 2013), and is now among the world’s top 100 universities by reputation (March 2014). In May 2014, it was ranked in the top 10 of all universities in the world for citation rate by the new EU-supported U-Multirank database, and fourth in the world for impact in medical sciences by the Leiden Ranking.

Zambart is a Zambian research organisation established in 2004 from a research collaboration between the School of Medicine University of Zambia and the London School of Hygiene and Tropical Medicine (LSHTM) that spans over 20 years. From the initial studies of the impact of HIV on the clinical presentation and outcome of Tuberculosis, the scope and partnership of the research have expanded widely.

Based in the School of Medicine Ridgeway campus of the University of Zambia in Lusaka, Zambart has grown to become one of the leading research groups supporting healthcare advances in TB and HIV. Since 1989, Zambart has actively partnered with the Zambian government through direct collaboration in healthcare research. Zambart also works closely with other research organizations and academic institutions within Africa, and worldwide to help innovatively reduce the public-health burden caused by the dual epidemics in resource-limited communities in Zambia and beyond.

Zambart has been actively involved in regional and international research consortia e.g. TARGETS, Evidence for Action, CREATE consortium. Internationally, Zambart is recognised as one of the foremost TB/HIV research groups in the world. Representatives sit on the WHO TB/HIV working group and have assisted in the writing of WHO technical guidelines and policy documents.